Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 178 citing articles:

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei, et al.
The Lancet (2021) Vol. 398, Iss. 10304, pp. 957-980
Open Access | Times Cited: 2470
Global vascular guidelines on the management of chronic limb-threatening ischemia
Michael S. Conte, Andrew W. Bradbury, Philippe Kolh, et al.
Journal of Vascular Surgery (2019) Vol. 69, Iss. 6, pp. 3S-125S.e40
Open Access | Times Cited: 1463
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
Michael S. Conte, Andrew W. Bradbury, Philippe Kolh, et al.
European Journal of Vascular and Endovascular Surgery (2019) Vol. 58, Iss. 1, pp. S1-S109.e33
Open Access | Times Cited: 1133
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Bin Zhou, Pablo Perel, George A. Mensah, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 11, pp. 785-802
Open Access | Times Cited: 970
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults
Pascal Geldsetzer, Jennifer Manne‐Goehler, Maja E. Marcus, et al.
The Lancet (2019) Vol. 394, Iss. 10199, pp. 652-662
Open Access | Times Cited: 706
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Marjan Walli-Attaei, Philip Joseph, Annika Rosengren, et al.
The Lancet (2020) Vol. 396, Iss. 10244, pp. 97-109
Closed Access | Times Cited: 267
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
Clara K Chow, Chinthanie Ramasundarahettige, Weihong Hu, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 6, Iss. 10, pp. 798-808
Closed Access | Times Cited: 162
Effect of salt substitution on community-wide blood pressure and hypertension incidence
Antonio Bernabé‐Ortiz, Víctor G. Sal y Rosas, Vilarmina Ponce-Lucero, et al.
Nature Medicine (2020) Vol. 26, Iss. 3, pp. 374-378
Open Access | Times Cited: 159
The household economic burden of non-communicable diseases in 18 countries
Adrianna Murphy, Benjamin Palafox, Marjan Walli-Attaei, et al.
BMJ Global Health (2020) Vol. 5, Iss. 2, pp. e002040-e002040
Open Access | Times Cited: 157
Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey
Mei Zhang, Yu Shi, Bin Zhou, et al.
BMJ (2023), pp. e071952-e071952
Open Access | Times Cited: 134
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
Clara K Chow, Emily Atkins, Graham S. Hillis, et al.
The Lancet (2021) Vol. 398, Iss. 10305, pp. 1043-1052
Open Access | Times Cited: 112
Hypertension in Low- and Middle-Income Countries
Aletta E. Schutte, Nikhil Srinivasapura Venkateshmurthy, Sailesh Mohan, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 808-826
Open Access | Times Cited: 111
Global and national high blood pressure burden and control
Tu Ngoc Nguyen, Clara K Chow
The Lancet (2021) Vol. 398, Iss. 10304, pp. 932-933
Closed Access | Times Cited: 105
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
Jiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
The Lancet (2023) Vol. 401, Iss. 10380, pp. 928-938
Closed Access | Times Cited: 58
World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update
Liliana Laranjo, Fernando Laņas, Marie Chan Sun, et al.
Global Heart (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 35
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka
Ruth Webster, Abdul Salam, H. Asita de Silva, et al.
JAMA (2018) Vol. 320, Iss. 6, pp. 566-566
Open Access | Times Cited: 153
Demographic, behavioral, and cardiovascular disease risk factors in the Saudi population: results from the Prospective Urban Rural Epidemiology study (PURE-Saudi)
Khalid F. AlHabib, Mohammed A. Batais, Turky H. Almigbal, et al.
BMC Public Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 120
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
Clara K Chow, Tu Ngoc Nguyen, Simone Marschner, et al.
BMJ Global Health (2020) Vol. 5, Iss. 11, pp. e002640-e002640
Open Access | Times Cited: 93
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
Muhammad Jami Husain, Biplab Datta, Deliana Kostova, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 9
Open Access | Times Cited: 88
Effectiveness of digital health interventions on blood pressure control, lifestyle behaviours and adherence to medication in patients with hypertension in low-income and middle-income countries: a systematic review and meta-analysis of randomised controlled trials
Vincent Boima, Alfred Doku, Francis Agyekum, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102432-102432
Open Access | Times Cited: 14
Gender differences in the association between healthy eating index-2015 and hypertension in the US population: evidence from NHANES 1999–2018
Jiayi Weng, Yukang Mao, Qiyang Xie, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Hypertension in Developing Countries: A Major Challenge for the Future
M. Mohsen Ibrahim
Current Hypertension Reports (2018) Vol. 20, Iss. 5
Closed Access | Times Cited: 78
Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries
Diane Macquart de Terline, A. Kane, Kouadio Euloge Kramoh, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0219266-e0219266
Open Access | Times Cited: 74
Fixed‐dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications
Donald J. DiPette, Jamario Skeete, Emily Ridley, et al.
Journal of Clinical Hypertension (2018) Vol. 21, Iss. 1, pp. 4-15
Open Access | Times Cited: 71
WHO HEARTS: A Global Program to Reduce Cardiovascular Disease Burden: Experience Implementing in the Americas and Opportunities in Canada
Norm R.C. Campbell, Pedro Ordúñez, Gloria Giraldo, et al.
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 5, pp. 744-755
Closed Access | Times Cited: 67
Page 1 - Next Page

Scroll to top